Association between human immunodeficiency virus infection and arterial stiffness in children

Justin S. Kuilder, Nikmah Salamia Idris, Diederick E. Grobbee, Michiel L. Bots, Michael M H Cheung, David Burgner, Nia Kurniati, Cuno S.P.M. Uiterwaal

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background Human immunodeficiency virus infection (HIV) is associated with increased cardiovascular risk and adverse cardiovascular outcome in adults. Early recognition of changes in vascular properties might prove essential in cardiovascular prevention in HIV-infected patients. We investigated the relations between HIV infection and arterial stiffness in children. Methods This cross-sectional study included 51 HIV-infected and 52 healthy children (age 3.2-14.5 years, 49 males). All infected children had acquired HIV by vertical transmission and were receiving antiretroviral therapy at time of assessment. Arterial stiffness was measured by pulse wave velocity and aortic augmentation index, using the Arteriograph system (Tensiomed Kft, Budapest, Hungary). We applied multivariable general linear modeling to evaluate the relationship between HIV infection and arterial stiffness with further adjustment for confounders and possible intermediary variables. Findings represent mean group differences with 95% confidence intervals and p values. Results Aortic augmentation index was higher by 9.0% (5.6-12.5, p < 0.001) in HIV-infected than in healthy children. Adjustment for blood pressure, protease inhibitor use, biomarkers for level of inflammation, lipid- and glucose-metabolism, as possible intermediary variables, did not appreciably alter the results. There were no significant differences in pulse wave velocity between HIV-infected and healthy children (mean difference 0.28 m/s, -0.14-0.69, p = 0.19). Conclusion HIV-infected children have an increased aortic augmentation index, compared to healthy children. Early cardiovascular assessment may be important in targeted prevention for HIV-infected children.

Original languageEnglish
Pages (from-to)480-488
Number of pages9
JournalEuropean Journal of Preventive Cardiology
Volume24
Issue number5
DOIs
Publication statusPublished - 1 Mar 2017

Keywords

  • arterial elasticity
  • cardiovascular risk
  • children
  • Human immunodeficiency virus

Cite this

Kuilder, J. S., Idris, N. S., Grobbee, D. E., Bots, M. L., Cheung, M. M. H., Burgner, D., ... Uiterwaal, C. S. P. M. (2017). Association between human immunodeficiency virus infection and arterial stiffness in children. European Journal of Preventive Cardiology, 24(5), 480-488. https://doi.org/10.1177/2047487316680694
Kuilder, Justin S. ; Idris, Nikmah Salamia ; Grobbee, Diederick E. ; Bots, Michiel L. ; Cheung, Michael M H ; Burgner, David ; Kurniati, Nia ; Uiterwaal, Cuno S.P.M. / Association between human immunodeficiency virus infection and arterial stiffness in children. In: European Journal of Preventive Cardiology. 2017 ; Vol. 24, No. 5. pp. 480-488.
@article{c068a00c859549faac1134dd293b4dc9,
title = "Association between human immunodeficiency virus infection and arterial stiffness in children",
abstract = "Background Human immunodeficiency virus infection (HIV) is associated with increased cardiovascular risk and adverse cardiovascular outcome in adults. Early recognition of changes in vascular properties might prove essential in cardiovascular prevention in HIV-infected patients. We investigated the relations between HIV infection and arterial stiffness in children. Methods This cross-sectional study included 51 HIV-infected and 52 healthy children (age 3.2-14.5 years, 49 males). All infected children had acquired HIV by vertical transmission and were receiving antiretroviral therapy at time of assessment. Arterial stiffness was measured by pulse wave velocity and aortic augmentation index, using the Arteriograph system (Tensiomed Kft, Budapest, Hungary). We applied multivariable general linear modeling to evaluate the relationship between HIV infection and arterial stiffness with further adjustment for confounders and possible intermediary variables. Findings represent mean group differences with 95{\%} confidence intervals and p values. Results Aortic augmentation index was higher by 9.0{\%} (5.6-12.5, p < 0.001) in HIV-infected than in healthy children. Adjustment for blood pressure, protease inhibitor use, biomarkers for level of inflammation, lipid- and glucose-metabolism, as possible intermediary variables, did not appreciably alter the results. There were no significant differences in pulse wave velocity between HIV-infected and healthy children (mean difference 0.28 m/s, -0.14-0.69, p = 0.19). Conclusion HIV-infected children have an increased aortic augmentation index, compared to healthy children. Early cardiovascular assessment may be important in targeted prevention for HIV-infected children.",
keywords = "arterial elasticity, cardiovascular risk, children, Human immunodeficiency virus",
author = "Kuilder, {Justin S.} and Idris, {Nikmah Salamia} and Grobbee, {Diederick E.} and Bots, {Michiel L.} and Cheung, {Michael M H} and David Burgner and Nia Kurniati and Uiterwaal, {Cuno S.P.M.}",
year = "2017",
month = "3",
day = "1",
doi = "10.1177/2047487316680694",
language = "English",
volume = "24",
pages = "480--488",
journal = "European Journal of Preventive Cardiology",
issn = "2047-4873",
publisher = "SAGE Publications Ltd",
number = "5",

}

Kuilder, JS, Idris, NS, Grobbee, DE, Bots, ML, Cheung, MMH, Burgner, D, Kurniati, N & Uiterwaal, CSPM 2017, 'Association between human immunodeficiency virus infection and arterial stiffness in children' European Journal of Preventive Cardiology, vol. 24, no. 5, pp. 480-488. https://doi.org/10.1177/2047487316680694

Association between human immunodeficiency virus infection and arterial stiffness in children. / Kuilder, Justin S.; Idris, Nikmah Salamia; Grobbee, Diederick E.; Bots, Michiel L.; Cheung, Michael M H; Burgner, David; Kurniati, Nia; Uiterwaal, Cuno S.P.M.

In: European Journal of Preventive Cardiology, Vol. 24, No. 5, 01.03.2017, p. 480-488.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Association between human immunodeficiency virus infection and arterial stiffness in children

AU - Kuilder, Justin S.

AU - Idris, Nikmah Salamia

AU - Grobbee, Diederick E.

AU - Bots, Michiel L.

AU - Cheung, Michael M H

AU - Burgner, David

AU - Kurniati, Nia

AU - Uiterwaal, Cuno S.P.M.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Background Human immunodeficiency virus infection (HIV) is associated with increased cardiovascular risk and adverse cardiovascular outcome in adults. Early recognition of changes in vascular properties might prove essential in cardiovascular prevention in HIV-infected patients. We investigated the relations between HIV infection and arterial stiffness in children. Methods This cross-sectional study included 51 HIV-infected and 52 healthy children (age 3.2-14.5 years, 49 males). All infected children had acquired HIV by vertical transmission and were receiving antiretroviral therapy at time of assessment. Arterial stiffness was measured by pulse wave velocity and aortic augmentation index, using the Arteriograph system (Tensiomed Kft, Budapest, Hungary). We applied multivariable general linear modeling to evaluate the relationship between HIV infection and arterial stiffness with further adjustment for confounders and possible intermediary variables. Findings represent mean group differences with 95% confidence intervals and p values. Results Aortic augmentation index was higher by 9.0% (5.6-12.5, p < 0.001) in HIV-infected than in healthy children. Adjustment for blood pressure, protease inhibitor use, biomarkers for level of inflammation, lipid- and glucose-metabolism, as possible intermediary variables, did not appreciably alter the results. There were no significant differences in pulse wave velocity between HIV-infected and healthy children (mean difference 0.28 m/s, -0.14-0.69, p = 0.19). Conclusion HIV-infected children have an increased aortic augmentation index, compared to healthy children. Early cardiovascular assessment may be important in targeted prevention for HIV-infected children.

AB - Background Human immunodeficiency virus infection (HIV) is associated with increased cardiovascular risk and adverse cardiovascular outcome in adults. Early recognition of changes in vascular properties might prove essential in cardiovascular prevention in HIV-infected patients. We investigated the relations between HIV infection and arterial stiffness in children. Methods This cross-sectional study included 51 HIV-infected and 52 healthy children (age 3.2-14.5 years, 49 males). All infected children had acquired HIV by vertical transmission and were receiving antiretroviral therapy at time of assessment. Arterial stiffness was measured by pulse wave velocity and aortic augmentation index, using the Arteriograph system (Tensiomed Kft, Budapest, Hungary). We applied multivariable general linear modeling to evaluate the relationship between HIV infection and arterial stiffness with further adjustment for confounders and possible intermediary variables. Findings represent mean group differences with 95% confidence intervals and p values. Results Aortic augmentation index was higher by 9.0% (5.6-12.5, p < 0.001) in HIV-infected than in healthy children. Adjustment for blood pressure, protease inhibitor use, biomarkers for level of inflammation, lipid- and glucose-metabolism, as possible intermediary variables, did not appreciably alter the results. There were no significant differences in pulse wave velocity between HIV-infected and healthy children (mean difference 0.28 m/s, -0.14-0.69, p = 0.19). Conclusion HIV-infected children have an increased aortic augmentation index, compared to healthy children. Early cardiovascular assessment may be important in targeted prevention for HIV-infected children.

KW - arterial elasticity

KW - cardiovascular risk

KW - children

KW - Human immunodeficiency virus

UR - http://www.scopus.com/inward/record.url?scp=85014424894&partnerID=8YFLogxK

U2 - 10.1177/2047487316680694

DO - 10.1177/2047487316680694

M3 - Article

VL - 24

SP - 480

EP - 488

JO - European Journal of Preventive Cardiology

JF - European Journal of Preventive Cardiology

SN - 2047-4873

IS - 5

ER -